ADMA Class Reminder: ADMA Biologics Investors are Reminded of the Upcoming August 10 Deadline in the Filed Securities Fraud Class Action to Recover Losses
Bleichmar Fonti & Auld LLP reminded ADMA Biologics investors of an August 10 deadline to seek lead plaintiff status in a securities fraud class action. The complaint alleges the company inflated 2025 growth through a channel stuffing scheme and failed to disclose related party transactions.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.